Overview

Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.

Status:
Completed
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
Evaluation of use of low dose tadalafil 5 mg daily for treatment of female OAB syndrome
Phase:
Phase 1
Details
Lead Sponsor:
Kasr El Aini Hospital
Treatments:
Tadalafil
Tolterodine Tartrate